Loading candles…
Max Healthcare Institute Limited operates in the healthcare industry in India, providing services through primary care clinics, multi-speciality hospitals, and super-speciality hospitals. The company offers operation and management services alongside medical, clinical, radiology, pathology, and other related healthcare services. It serves multiple locations in North India, including Delhi NCR, Mumbai, Mohali, Bathinda, Dehradun, Lucknow, and Nagpur. As of December 2025, Max Healthcare is the largest hospital chain in India by market capitalization and ranks second by revenue and EBITDA. The company focuses on tertiary and quaternary healthcare services, positioning itself as a significant provider within the Indian healthcare sector.
This page is a live market overview for MAX HEALTHCARE INS LTD (MAXHEALTH) on the NSE. As a listed security, MAX HEALTHCARE INS LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for MAXHEALTH before placing trades on tick2trade.
As of the latest feed, MAXHEALTH last traded at ₹1,070 on NSE, down ₹2.4 (0.22%) from the previous close of ₹1,072.4. Today's session range is ₹1,067 – ₹1,084.3, against a 52-week band of ₹903 – ₹1,301.7. Traded volume today stands at 11.90L shares.
The overview consolidates an interactive price chart with multiple time ranges, a near-the-money option chain snapshot, recent market headlines, upcoming corporate events for MAXHEALTH in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether MAXHEALTH is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for MAX HEALTHCARE INS LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in MAXHEALTH. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated MAXHEALTH option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - Q4 & FY26 | To consider and approve the financial results for the quarter and financial year ended March 31, 2026 and dividend | 21 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 5 Feb 2026 |
| Results - Q2 & FY25 | To consider and approve the financial results for the quarter and half year ended September 30, 2025 | 14 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 13 Aug 2025 |
| Results - Q4 & FY25 | To consider and approve the financial results for the quarter and financial year ended March 31, 2025 and dividend | 20 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.